One reason form looking closely at bacteriophages is due to the rise in multi-drug antimicrobial resistance among pathogenic bacteria. This rise in resistance and the associated challenges in finding alternative compounds has led to a growth in interest in alternatives. Among the alternatives are bacteriophages; an interest that stems from their special characteristics, including widespread distribution, self-replication, and a lack of effects on the host. This article assesses current research.
Tim Sandle has written a review arricle about bacteriophage research, for Pharmig News #83 (pp14-17).
The article can be accessed here: https://www.researchgate.net/publication/350850436_Bacteriophages_as_antibacterial_therapies
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)